Kyntra Bio, Inc. (KYNB) Stock Ticker
Market factors today
Unlock the full KYNB picture
About Kyntra Bio, Inc.
Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to create groundbreaking therapies aimed at tackling conditions like anemia, various fibrotic disorders, and different forms of cancer. Established by Thomas B. Neff on September 29, 1993, the firm's main offices are situated in San Francisco, California.
KYNB stock facts
| Ticker symbol | KYNB |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $28.1M |
| CEO | Thane Wettig |
| Employees | 34 |
| Headquarters | San Francisco, CA, US |
| IPO date | 2014-11-14 |
| Website | www.kyntrabio.com |
What you can see for KYNB on Tickr
Live KYNB price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KYNB report.
Rankings
FAQ
What is the ticker symbol for Kyntra Bio, Inc.?
The ticker symbol for Kyntra Bio, Inc. is KYNB, listed on the NASDAQ Global Market.
What is KYNB?
Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to…